A phase I trial of OMS-527

Trial Profile

A phase I trial of OMS-527

Phase of Trial: Phase I

Latest Information Update: 16 Nov 2017

At a glance

  • Drugs OMS 527 (Primary)
  • Indications Drug dependence; Obsessive-compulsive disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Nov 2017 New trial record
    • 09 Nov 2017 According to an Omeros Corporation media release, OMS-527 is on track to enter phase I trial in the first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top